| Michael A Donnelly, DO FACOS | |
|
1905 E. Huebbe Parkway, Beloit Health System Inc., Beloit, WI 53511-1842 | |
| (608) 364-2200 | |
| (608) 364-2705 |
| Full Name | Michael A Donnelly |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 38 Years |
| Location | 1905 E. Huebbe Parkway, Beloit, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831107671 | NPI | - | NPPES |
| 10631 | Other | DEAN HEALTH PLAN HMO | |
| 1831107671 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 33488021 (Wisconsin) | Primary |
| 208800000X | Urology | 036-075916 (Illinois) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beloit Health System | Beloit, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beloit Health System Inc | 8224947858 | 110 |
News Archive
An app that can measure fitness at home by hospital out-patients is being shared for free by its Malmö University developer. Such technology could be vital in reducing the number of appointments high risk groups must attend.
Duke University researchers have found a "roving detection system" on the surface of cells that may point to new ways of treating diseases like cancer, Parkinson's disease and amyotrophic lateral sclerosis (ALS).
Scientists are already preparing for a possible next coronavirus pandemic to strike, keeping with the seven-year pattern since 2004.
Polyplus-transfection SA, a privately-held company developing innovative technologies for molecular and cellular biology, announces today that it has granted two agencies of the United States National Institutes of Health a non-exclusive, research license to use Polyethylenimine (PEI) for in vitro transfection applications. The two agencies are the National Institute of Allergy and Infectious Diseases and the National Cancer Institute.
Synexus, the world's largest company responsible for the recruitment and running of clinical trials, has won its first contract to conduct ophthalmology studies.
› Verified 3 days ago
| Entity Name | Beloit Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568677417 PECOS PAC ID: 8224947858 Enrollment ID: O20031215000424 |
News Archive
An app that can measure fitness at home by hospital out-patients is being shared for free by its Malmö University developer. Such technology could be vital in reducing the number of appointments high risk groups must attend.
Duke University researchers have found a "roving detection system" on the surface of cells that may point to new ways of treating diseases like cancer, Parkinson's disease and amyotrophic lateral sclerosis (ALS).
Scientists are already preparing for a possible next coronavirus pandemic to strike, keeping with the seven-year pattern since 2004.
Polyplus-transfection SA, a privately-held company developing innovative technologies for molecular and cellular biology, announces today that it has granted two agencies of the United States National Institutes of Health a non-exclusive, research license to use Polyethylenimine (PEI) for in vitro transfection applications. The two agencies are the National Institute of Allergy and Infectious Diseases and the National Cancer Institute.
Synexus, the world's largest company responsible for the recruitment and running of clinical trials, has won its first contract to conduct ophthalmology studies.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael A Donnelly, DO FACOS 1905 E. Huebbe Parkway, Beloit Health System Inc., Beloit, WI 53511-1842 Ph: (608) 364-2200 | Michael A Donnelly, DO FACOS 1905 E. Huebbe Parkway, Beloit Health System Inc., Beloit, WI 53511-1842 Ph: (608) 364-2200 |
News Archive
An app that can measure fitness at home by hospital out-patients is being shared for free by its Malmö University developer. Such technology could be vital in reducing the number of appointments high risk groups must attend.
Duke University researchers have found a "roving detection system" on the surface of cells that may point to new ways of treating diseases like cancer, Parkinson's disease and amyotrophic lateral sclerosis (ALS).
Scientists are already preparing for a possible next coronavirus pandemic to strike, keeping with the seven-year pattern since 2004.
Polyplus-transfection SA, a privately-held company developing innovative technologies for molecular and cellular biology, announces today that it has granted two agencies of the United States National Institutes of Health a non-exclusive, research license to use Polyethylenimine (PEI) for in vitro transfection applications. The two agencies are the National Institute of Allergy and Infectious Diseases and the National Cancer Institute.
Synexus, the world's largest company responsible for the recruitment and running of clinical trials, has won its first contract to conduct ophthalmology studies.
› Verified 3 days ago
Kevin M Tomera, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1905 E. Huebbe Parkway, Beloit Clinic, Beloit, WI 53511 Phone: 608-364-2470 Fax: 608-363-7378 | |
Larry M Ojeda, MD Urology Medicare: Medicare Enrolled Practice Location: 1905 E. Huebbe Parkway, Beloit Health System Inc., Beloit, WI 53511 Phone: 608-364-2200 Fax: 608-364-2705 |